Research at Oslo University Hospital

 

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic rsearch, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

 

Latest news

March 5th 12-15, Rh Gaustad:

Seminar with the winners of the Olav Thon Foundation International Research Prize

 

This is a unique seminar with the winners of the Olav Thon Foundation International Research Prize within the fields of medical as well as mathematics and natural sciences for 2015: Judith Campisi (Buck Institute for Research on Aging, USA) and Yossi Shiloh (Tel Aviv University, Israel). Doctor of honour at the University of Oslo, Vilhelm A. Bohr, NIH, will conclude the seminar with his lecture.

The seminar is a collaboration between the Olav Thon Foundation, University of Oslo (UiO) the Healthy Brain Ageing Centre (HBAC) research network and Tone Tønjum's Genome Network group at Oslo University Hospital / UiO.

Time: Thursday, March 5th, 2015 at 12:00 - 15:00
Place: DM4, The Rotunda at University of Oslo (UiO), Gaustad

 
 

Article from Kirsten Skarstad's group published in Nucleic Acids Research

 
Joint first authors Helgesen (left) and Fossum-Raunehaug
Joint first authors Helgesen (left) and Fossum-Raunehaug

Emily Helgesen and Solveig Fossum-Raunehaug (photo) from Kirsten Skarstad's group at the Department of Molecular Cell Biology at the Institute for Cancer Research are joint first authors on an article recently published in "Nucleic Acids Research" (journal impact factor 8.8).
In this paper they demonstrate how specific protein complexes that dynamically bind the new DNA generated by the replication forks organize the newly replicated DNA at a considerable distance from the replisome.

 
 

Kari Kværner blogs about research based innovation

 
Kari Kværner
Kari Kværner

Kari Kværner, head of the Innovation section at Oslo University Hospital and leader of the "Centre for Connected Care – Accelerating adoption and diffusion of patient-centric innovations" - one 17 new Centres for Research-based Innovation (SFI) appointed by the Research Council of Norway - has recently written an article for the the Oslo University Hospital research blog (in Norwegian). The title of her piece is (translated to) "We must listen end learn in order to deliver what the patients need".
The SFI centre she will be leading starts up August 15th, and has a total budget of 217,6 mill NOK, securing operation for 8 years.

 
 

Research on cancer vaccines against follicular lymphoma presented by the Norwegian Cancer Society

 
From left: Johanna Olweus, Arne Kolstad og Shraddha Kumari (photo Terje Heiestad)
From left: Johanna Olweus, Arne Kolstad og Shraddha Kumari (photo Terje Heiestad)

The research section of the Norwegian Cancer Society (NCS) publish articles about scientists they support regularly, written in a popular scientific language (in Norwegian). They have recently published a piece about the research on the use of cancer vaccines in order to fight Follicular lymphoma, performed by the research groups led by Arne Kolstad and Johanne Olweus at the Department of Oncology and the Institute for Cancer Research, Oslo University Hospital.

 
 

Kristin Bjordal blogs about clinical research participation

 
Kristin Bjordal
Kristin Bjordal

Kristin Bjordal, head of research at the Oslo Hospital Services division and professor II at the Institute of Clinical Medicine, UiO, has recently written for the the Oslo University Hospital research blog (in Norwegian). She discusses various aspects of participating in clinical studies, including risks and gains.

 
 

Recent article in Oncogene from Kristian Berg's PCI research group

 
Berstad (left) and Weyergang: first and last authors
Berstad (left) and Weyergang: first and last authors

Maria EB Berstad and Anette Weyergang in Kristian Bergs Photochemical internalisation (PCI) research group are the first and last authors of a recent publication in Oncogene (journal impact factor 8.6) on design and evaluation of an EGFR targeting toxin for photochemical delivery.